Skip to main content
ADCT logo
ADCT
(NYSE)
ADC Therapeutics SA
$3.78-- (--)
Loading... - Market loading

ADC Therapeutics SA (ADCT) Stock Price & Financial Analysis

ADC Therapeutics SA Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.60 - $3.97
52-Week High$4.98
52-Week Low$1.05
Open$3.70
Volume1.36M
Average Volume (3M)1.36M
Market Cap568.14M
Shares Outstanding150.30M
Price to Sales (P/S)7.02
EV/EBITDA-6.68
Revenue (TTM)81.36M
Net Income (TTM)-142.62M
Free Cash Flow (TTM)-141.45M
EPS (TTM)$-0.95
Profit Margin-175.31%
Operating Margin-115.40%
50-Day MA$4.02
200-Day MA$3.67
52-Week Change181.48%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ADC Therapeutics SA

What is the current stock price for ADCT?

As of the latest trading session, ADCT stock trades at $3.78. The 52-week range is $1.05–$4.98, with a day range of $3.60–$3.97.

What is the P/E ratio for ADCT?

The P/E ratio (Price-to-Earnings) for ADCT is shown in the Key Statistics section. This valuation metric helps compare ADC Therapeutics SA to industry peers.

Does ADCT pay dividends?

ADC Therapeutics SA does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADCT?

Based on 1 analyst, the consensus for ADCT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ADCT?

ADC Therapeutics SA's market capitalization is $568.1M, classifying it as a small-cap company. ADC Therapeutics SA operates in the Healthcare sector within the Biotechnology industry.